Open access · CC-BY
via OpenAlex
Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
Adrian Kołakowski, Sylwia Dziemitko, Aleksandra Chmielecka, Hubert Żywno, Wiktor Bzdęga, Tomasz Charytoniuk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka
International Journal of Molecular Sciences · 2022 · ▲ 6 citations
Abstract
Metabolic-Associated Fatty Liver Disease (MAFLD) is a major cause of liver diseases globally and its prevalence is expected to grow in the coming decades. The main cause of MAFLD development is changed in the composition of the extracellular matrix (ECM). Increased production of matrix molecules and inflammatory processes lead to progressive fibrosis, cirrhosis, and ultimately liver failure. In addition, increased accumulation of sphingolipids accompanied by increased expression of pro-inflammatory cytokines in the ECM is closely related to lipogenesis, MAFLD development, and its progression to fibrosis. In our work, we will summarize all information regarding the role of sphingolipids e.g., ceramide and S1P in MAFLD development. These sphingolipids seem to have the most significant effect on macrophages and, consequently, HSCs which trigger the entire cascade of overproduction matrix molecules, especially type I and III collagen, proteoglycans, elastin, and also tissue inhibitors of metalloproteinases, which as a result cause the development of liver fibrosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms231911380
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Kołakowski, A., Dziemitko, S., Chmielecka, A., Żywno, H., Bzdęga, W., Charytoniuk, T., Chabowski, A., & Konstantynowicz-Nowicka, K. (2022). Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms231911380
Vancouver
Kołakowski A, Dziemitko S, Chmielecka A, Żywno H, Bzdęga W, Charytoniuk T, et al. Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms231911380.
BibTeX
@article{adrian2022Molecu,
title = {Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis},
author = {Adrian Kołakowski and Sylwia Dziemitko and Aleksandra Chmielecka and Hubert Żywno and Wiktor Bzdęga and Tomasz Charytoniuk and Adrian Chabowski and Karolina Konstantynowicz-Nowicka},
journal = {International Journal of Molecular Sciences},
year = {2022},
doi = {10.3390/ijms231911380},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Annals of Translational Medicine 2021
Open access · CC-BY
It’s all about the spaces between cells: role of extracellular matrix in liver fibrosis
Bioscience Reports 2016
Open access · CC-BY
Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis
The Journal of Pathology 2003
Open access · OA
Liver extracellular matrix in health and disease
The Journal of Immunology 2010
Open access · OA
Matrix Metalloproteinase 12-Deficiency Augments Extracellular Matrix Degrading Metalloproteinases and Attenuates IL-13–Dependent Fibrosis
Matrix Biology 2018
Preprint · OA
Extracellular matrix in lung development, homeostasis and disease
Phytotherapy Research 2023
Open access · CC-BY